Prostate cancer (US version)

Finding the right ADT for the right patient

Ottienti punti di accreditamento

Finish 5 case(s) answer 10 question(s) and Earn 1 credit.

Continua
Obiettivo della formazione: See below.
Specializzazione: Urology, Radiation Oncology, Medical Oncology
Pubblico target: CME (basic, intermediate), Residents (senior)
Aggiornamento più recente: September 2023
Premessa:

Learning objectives:

Upon completion of this ACCME-accredited CME program, the participants will be better able to:

  1. identify the role of androgen-deprivation therapy (ADT) in the management of prostate cancer
  2. select which patients will benefit from ADT 
  3. choose the most appropriate ADT for selected prostate cancer patients
  4. assess the relevance and impact of recent data on ADT for the management of (advanced) prostate cancer.

Educational Activity: Online Case-Based CME Program

Credits Offered: 1.00 AMA PRA Category 1 Credit(s)™

Release Date/End Date: 01/30/2023 - 02/15/2024

Estimated Run Time: 1 hour

Faculty/Panel Members:

SC: Scientific Committee member.

Accreditation Statement: In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME),  American Nurses Credentialing Center (ANCC), and the Accreditation Council for Pharmacy Education (ACPE), to provide continuing education for the healthcare team.

Designation Statement: Rush University Medical Center designates this internet enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosure Information: Rush University Medical Center has mechanisms in place to identify and resolve any potential conflicts of interest on the part of faculty and planners prior to the start of the activity. Individuals in control of content have disclosed the following:

All of the relevant financial relationships listed for these individuals have been mitigated. The remaining faculty and reviewers of this activity have no relevant financial relationship(s) with ineligible companies to disclose.

Unapproved Uses of Drugs/Devices:  In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices.  Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.

 

This activity is funded in part by an unrestricted grant from Astellas.